Skip to Content

New Drug Approvals Archive - November 2003

November 2003

Climara Pro (estradiol and levonorgestrel ) Transdermal System

Date of Approval: November 21, 2003
Company: Berlex Laboratories
Treatment for: Postmenopausal Symptoms

Climara Pro (estradiol and levonorgestrel) is a transdermal combined hormone therapy for the relief of moderate to severe vasomotor symptoms associated with menopause, such as hot flashes and night sweats.

Cialis (tadalafil) Tablets

Date of Approval: November 21, 2003
Company: Eli Lilly and Co.
Treatment for: Erectile Dysfunction, Benign Prostatic Hyperplasia

Cialis is a phosphodiesterase 5 (PDE5) inhibitor indicated for erectile dysfunction, and to treat the signs and symptoms of benign prostatic hyperplasia.

Climara Pro (estradiol and levonorgestrel ) Transdermal System

Date of Approval: November 21, 2003
Company: Berlex Laboratories
Treatment for: Postmenopausal Symptoms

Climara Pro (estradiol and levonorgestrel) is a transdermal combined hormone therapy for the relief of moderate to severe vasomotor symptoms associated with menopause, such as hot flashes and night sweats.

Cialis (tadalafil)

New Indication Approved: October 7, 2011

New Drug Approvals Archive